Healthcare

Research and innovation addressing today's greatest health challenges

Using IoT, AI and cloud technologies to advance home-based integrated care

One of the largest growing demographics in the EU is individuals aged 65 and over, and two thirds of this group are in situation of multimorbidity, i.e., perons who suffer from two or more chronic diseases. The ineffective treatment of multimorbidity has been pointed out as an urgent problem to address by the Academy of […]

Continue reading

Using Deep Learning to Predict Emergency Room Visits

At IBM Research, we are using deep learning to explore new solutions for a range of health care challenges. One such challenge is emergency room (ER) overcrowding, which can lead to long wait times for treatment. Overcrowding results in part from people visiting the ER for non-emergency conditions rather than relying on primary physicians. Patients […]

Continue reading

IBM Names 2018 Fellows, Including Four IBM Researchers

Half of IBM’s 2018 Fellows Hail from IBM Research For more than 70 years, IBM Research has defined the future of technology for IBM. Today, we lead the way forward in AI, blockchain, quantum computing and cybersecurity, thanks to critical foundational research conducted across our global labs. This defining moment in IBM’s transformation is made […]

Continue reading

Mastering the Flow of Tiny Biological Liquids with Electrogates

Today, much of the knowledge we have in biology and medicine is derived from the ability to detect analytes from complex biological samples, such as blood and urine. This knowledge, in the form of data, is vital for patient diagnostics. For more than a decade, IBM scientists have taken their years of experience from the […]

Continue reading

New Study: Synthetic Macromolecules Kill Multidrug-Resistant Cancer Cells

Cancer continues to be a deadly threat to more than 14 million people who are diagnosed each year around the world. At the same time, five-year survival rates have been steadily improving over the last three decades to nearly 70 percent, according to the American Cancer Society. However, current cancer treatment regimens, such as traditional […]

Continue reading

A new molecule designed to kill deadly, drug-resistant superbugs

In 2016, I had a bacterial infection that I acquired after a routine knee surgery. Fortunately, my immune system reacted favorably to antibiotics, but had the bacteria been a “superbug,” resistant to medication, my story might have had a different ending. This incident inspired me to focus my work on discovering a new solution. With […]

Continue reading

Computational Biologists Find Inspiration for Machine Learning Cell Cycle Sorting Method in an Unlikely Place

The lifespan of cells in the human body varies greatly, from as short as a few days, such as those in our stomach lining, to the cells in our bones, which live for 25-30 years. And for each healthy cell, no matter how long it lives, there is a tightly coordinated series of events that […]

Continue reading

Prediction of psychotic onset with AI: words portend the future

Psychiatrists characterize schizophrenia, a mental condition with devastating effects on those who suffer it, by a set of intuitively understandable concepts including “poverty of speech” and “flight of ideas.” These concepts, however, are subjective in the sense that their quantification depends significantly on the particular training and ultimate judgment of individual psychiatrists. The evaluation of […]

Continue reading

Published in Science: IBM and Memorial Sloan Kettering researchers solve cancer immunotherapy mystery

Cancer immunotherapies, treatment approaches which harness a person’s own immune system to target and kill cancer cells, are currently a major driver in the development of new cancer treatments.  With the advent of next-generation gene editing technologies like CRISPR-Cas9, one could imagine a future in which cancer treatments are tailor-made not only for particular cancer […]

Continue reading

Genomics and AI push the boundary of precision medicine in blood cancer

Every nine minutes, someone in the US dies from blood cancer which accounts for about 10 percent of all cancer deaths. And, every three minutes, one person in the US is diagnosed with a blood cancer — about 170,000 people annually.  In 2017, 62,130 people were expected to be diagnosed with leukemia. [1] These numbers […]

Continue reading

New Research: Unlocking the secrets of Huntington’s Disease

Huntington’s disease (HD) is a devastating neurological disorder that causes death in neurons – a major component of the brain – and eventually the loss of physical and mental abilities. Currently, there are only very limited treatment options. IBM and CHDI Foundation have published research in the Journal of American Chemical Society1 detailing structural features […]

Continue reading

Publishing in The Lancet’s EBioMedicine: New research in AI pushes frontiers in epileptic seizure prediction

Today, The Lancet’s EBioMedicine journal will publish a study led by scientists from IBM Research-Australia and the University of Melbourne marking important progress in personalized seizure forecasting with AI. The findings, described in a paper titled ‘Epileptic Seizure Prediction using Big Data and Deep Learning: Toward a Mobile System,’ present new results in epileptic seizure […]

Continue reading